Something went wrong while submitting the form. Please, contact via us direct email info@translucencebio.comand
Recent news
January 31, 2023
Updates
Translucence Biosystems Participates in Keystone Meeting on Drug Delivery to the Brain
Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."
The Translucence team, including Nate Guanzon, Chase Redd, and CEO Damian Wheeler presented our BRAIN Initiative-funded work on whole-brain quantification neuronal activity with Npas4 and cFos at SfN 2022.
Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium
Co-Founder, Sunil Gandhi Ph.D., presents at the 8th Annual Bench to Bedside Symposium hosted by the Gavin Herbert Eye Institute at the University of California, Irvine School of Medicine.